ASX Announcement

Firebrick Update on Nasodine Phase 3 Trial

Published: 31/10/22, 04:37pm (AEST)3 pages
Firebrick Pharma Limited
FRE:ASXHealthcare

Recent FRE Announcements

Price Sensitive only